vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunosuppresseurs - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
vyvgart solution
argenx bv - efgartigimod alfa - solution - 20mg - efgartigimod alfa 20mg
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 24mg - lenvatinib (mésylate de lenvatinib) 24mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 20mg - lenvatinib (mésylate de lenvatinib) 20mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 14mg - lenvatinib (mésylate de lenvatinib) 14mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 10mg - lenvatinib (mésylate de lenvatinib) 10mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 8mg - lenvatinib (mésylate de lenvatinib) 8mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 18mg - lenvatinib (mésylate de lenvatinib) 18mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 4mg - lenvatinib (mésylate de lenvatinib) 4mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 12mg - lenvatinib (mésylate de lenvatinib) 12mg - antineoplastic agents